Center for Substance Abuse Prevention; Notice of Meeting, 82408-82409 [2010-32858]

Download as PDF 82408 Federal Register / Vol. 75, No. 250 / Thursday, December 30, 2010 / Notices Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Megan Homer, Writer/Editor, Office of Communications and Public Liaison, NIH, Building 31C Room 5C27, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free number 301–496–1752 or E-mail your request, including your address to: homerm@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: December 20, 2010. Lynn Hellinger, Director of Management, National Institutes of Health. [FR Doc. 2010–32911 Filed 12–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES jlentini on DSKJ8SOYB1PROD with NOTICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. VerDate Mar<15>2010 16:35 Dec 29, 2010 Jkt 223001 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Initial Review Group; Interventions Committee for Disorders Involving Children and Their Families. Date: January 31, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: David I. Sommers, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606. 301–443–7861. dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group; Mental Health Services in Non-Specialty Settings. Date: February 8, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Aileen Schulte, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608. 301–443–1225. aschulte@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group; Interventions Committee for Adult Disorders. Date: February 8, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: David I. Sommers, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606. 301–443–7861. dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group; Mental Health Services in MH Specialty Settings. Date: February 11, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Marina Broitman, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6153, MSC 9608, Bethesda, MD 20892–9608. 301–402–8152. mbroitma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: December 23, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–32907 Filed 12–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention Drug Testing Advisory Board (DTAB) on January 26 and 27, 2011. A portion of the meeting will be open and will include the Federal drug testing updates from the Department of Transportation, the Department of Defense, the Nuclear Regulatory Commission, and the Federal Drug-Free Workplace Programs; updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs (the Guidelines); review of the topics that the DTAB will be addressing in the future, including alternate matrices, the electronic custody and control form, and the medical review officer certification; a historical perspective of oral fluid as a drug testing matrix; and the current perspective of the oral fluid matrix, including specimen, drug analytes and their cutoffs, methodologies, proficiency testing, best practices experiences, and specimen drug testing data. The public is invited to attend the open session in person or to listen via teleconference. Due to the limited space, attendance will be on a registration-only basis. Public comments are welcome. To register, to make arrangements to attend, to obtain the teleconference call-in numbers and access codes, to submit E:\FR\FM\30DEN1.SGM 30DEN1 Federal Register / Vol. 75, No. 250 / Thursday, December 30, 2010 / Notices written or brief oral comments, or to request special accommodations for persons with disabilities, please register at the SAMHSA Committees’ Web site at https://nac.samhsa.gov/Registration/ meetingsRegistration.aspx or communicate with DTAB’s Program Assistant, Ms. Giselle Hersh (see contact information below). The Board will also meet to discuss proposed revisions to the Guidelines on January 27 between 1:30 p.m.–5 p.m. EST. This portion of the meeting will be conducted in a closed session as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d). Substantive program information, a summary of the meeting, and a roster of DTAB members may be obtained as soon as possible after the meeting, either by accessing the SAMHSA Committee Web site, https://www.nac.samhsa.gov/ DTAB/meetings.aspx, or by contacting Dr. Cook. The transcript for the open meeting will also be available on the SAMHSA Committee Web site within three weeks after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention Drug Testing Advisory Board. Date/Time/Type: January 26, 2011 from 11 a.m. to 5 p.m. EST: Open; January 27, 2011 from 8:30 a.m. to 12:15 p.m. EST: Open; January 27, 2011 from 1:30 p.m. to 5 p.m. EST: Closed. Place: Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry Road, Rockville, Maryland 20857. Contacts: Janine Denis Cook, PhD, Designated Federal Official, SAMHSA Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2–1045, Rockville, Maryland 20857. Telephone: 240–276–2600. Fax: 240– 276–2610. E-mail: janine.cook@samhsa.hhs.gov. Ms. Giselle Hersh, Program Assistant, SAMHSA Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2–1042, Rockville, Maryland 20857. Telephone: 240–276–2600. Fax: 240–276–2610. E-mail: Giselle.Hersh@samhsa.hhs.gov. jlentini on DSKJ8SOYB1PROD with NOTICES Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. 2010–32858 Filed 12–29–10; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5375–N–51] Federal Property Suitable as Facilities To Assist the Homeless Office of the Assistant Secretary for Community Planning and Development, HUD. ACTION: Notice. AGENCY: This Notice identifies unutilized, underutilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless. FOR FURTHER INFORMATION CONTACT: Juanita Perry, Department of Housing and Urban Development, 451 Seventh Street, SW., Room 7262, Washington, DC 20410; telephone (202) 708–1234; TTY number for the hearing- and speech-impaired (202) 708–2565, (these telephone numbers are not toll-free), or call the toll-free Title V information line at 800–927–7588. SUPPLEMENTARY INFORMATION: In accordance with the December 12, 1988 court order in National Coalition for the Homeless v. Veterans Administration, No. 88–2503–OG (D.D.C.), HUD publishes a Notice, on a weekly basis, identifying unutilized, underutilized, excess and surplus Federal buildings and real property that HUD has reviewed for suitability for use to assist the homeless. Today’s Notice is for the purpose of announcing that no additional properties have been determined suitable or unsuitable this week. SUMMARY: Dated: December 23, 2010. Mark R. Johnston, Deputy Assistant Secretary for Special Needs. [FR Doc. 2010–32792 Filed 12–29–10; 8:45 am] BILLING CODE 4210–67–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–R9–IA–2010–N286; 96300–1671– 0000–P5] Endangered Species; Receipt of Applications for Permit Fish and Wildlife Service, Interior. ACTION: Notice of receipt of applications for permit. AGENCY: We, the U.S. Fish and Wildlife Service (USFWS), invite the public to comment on the following applications to conduct certain activities with endangered species. With SUMMARY: VerDate Mar<15>2010 16:35 Dec 29, 2010 Jkt 223001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 82409 some exceptions, the Endangered Species Act (ESA) prohibits activities with listed species unless a Federal permit is issued that allows such activities. The ESA laws require that we invite public comment before issuing these permits. DATES: We must receive comments or requests for documents on or before January 31, 2011. ADDRESSES: Brenda Tapia, Division of Management Authority, U.S. Fish and Wildlife Service, 4401 North Fairfax Drive, Room 212, Arlington, VA 22203; fax (703) 358–2280; or e-mail DMAFR@fws.gov. FOR FURTHER INFORMATION CONTACT: Brenda Tapia, (703) 358–2104 (telephone); (703) 358–2280 (fax); DMAFR@fws.gov (e-mail). SUPPLEMENTARY INFORMATION: I. Public Comment Procedures A. How do I request copies of applications or comment on submitted applications? Send your request for copies of applications or comments and materials concerning any of the applications to the contact listed under ADDRESSES. Please include the Federal Register notice publication date, the PRTnumber, and the name of the applicant in your request or submission. We will not consider requests or comments sent to an e-mail or address not listed under ADDRESSES. If you provide an e-mail address in your request for copies of applications, we will attempt to respond to your request electronically. Please make your requests or comments as specific as possible. Please confine your comments to issues for which we seek comments in this notice, and explain the basis for your comments. Include sufficient information with your comments to allow us to authenticate any scientific or commercial data you include. The comments and recommendations that will be most useful and likely to influence agency decisions are: (1) Those supported by quantitative information or studies; and (2) Those that include citations to, and analyses of, the applicable laws and regulations. We will not consider or include in our administrative record comments we receive after the close of the comment period (see DATES) or comments delivered to an address other than those listed above (see ADDRESSES). B. May I review comments submitted by others? Comments, including names and street addresses of respondents, will be E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

[Federal Register Volume 75, Number 250 (Thursday, December 30, 2010)]
[Notices]
[Pages 82408-82409]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32858]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Substance Abuse and Mental Health Services 
Administration (SAMHSA) Center for Substance Abuse Prevention Drug 
Testing Advisory Board (DTAB) on January 26 and 27, 2011.
    A portion of the meeting will be open and will include the Federal 
drug testing updates from the Department of Transportation, the 
Department of Defense, the Nuclear Regulatory Commission, and the 
Federal Drug-Free Workplace Programs; updates on the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (the 
Guidelines); review of the topics that the DTAB will be addressing in 
the future, including alternate matrices, the electronic custody and 
control form, and the medical review officer certification; a 
historical perspective of oral fluid as a drug testing matrix; and the 
current perspective of the oral fluid matrix, including specimen, drug 
analytes and their cutoffs, methodologies, proficiency testing, best 
practices experiences, and specimen drug testing data.
    The public is invited to attend the open session in person or to 
listen via teleconference. Due to the limited space, attendance will be 
on a registration-only basis. Public comments are welcome. To register, 
to make arrangements to attend, to obtain the teleconference call-in 
numbers and access codes, to submit

[[Page 82409]]

written or brief oral comments, or to request special accommodations 
for persons with disabilities, please register at the SAMHSA 
Committees' Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or communicate with DTAB's Program Assistant, 
Ms. Giselle Hersh (see contact information below).
    The Board will also meet to discuss proposed revisions to the 
Guidelines on January 27 between 1:30 p.m.-5 p.m. EST. This portion of 
the meeting will be conducted in a closed session as determined by the 
Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 
U.S.C. App. 2, Section 10(d).
    Substantive program information, a summary of the meeting, and a 
roster of DTAB members may be obtained as soon as possible after the 
meeting, either by accessing the SAMHSA Committee Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or by contacting Dr. Cook. The 
transcript for the open meeting will also be available on the SAMHSA 
Committee Web site within three weeks after the meeting.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Date/Time/Type: January 26, 2011 from 11 a.m. to 5 p.m. EST: 
Open; January 27, 2011 from 8:30 a.m. to 12:15 p.m. EST: Open; 
January 27, 2011 from 1:30 p.m. to 5 p.m. EST: Closed.
    Place: Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry 
Road, Rockville, Maryland 20857.
    Contacts: Janine Denis Cook, PhD, Designated Federal Official, 
SAMHSA Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2-
1045, Rockville, Maryland 20857. Telephone: 240-276-2600. Fax: 240-
276-2610. E-mail: janine.cook@samhsa.hhs.gov.
    Ms. Giselle Hersh, Program Assistant, SAMHSA Drug Testing 
Advisory Board, 1 Choke Cherry Road, Room 2-1042, Rockville, 
Maryland 20857. Telephone: 240-276-2600. Fax: 240-276-2610. E-mail: 
Giselle.Hersh@samhsa.hhs.gov.

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 2010-32858 Filed 12-29-10; 8:45 am]
BILLING CODE 4162-20-P